Access to medicines key concern for consumers

Image
ANI New Delhi
Last Updated : Oct 30 2015 | 5:22 PM IST

In a joint survey conducted by PHD Chamber of Commerce and Industry and 1mg technologies on challenges faced by consumers while buying medicines from pharmacies, it has been stressed that an overwhelming majority of patients seek more convenient ways to get their medicine.

They face problem of visiting multiple pharmacies to get all their medicines and also notice price difference across pharmacies for the same drug.

Array

Releasing its findings, here on Tuesday, the two organizations say that 86.5 percent customers face the problem of visiting multiple pharmacies to get all their medicines whereas 92.2 percent people notice price difference across pharmacies for the same drug. It also highlights that 98 percent people like the convenience of door step delivery of the medicines.

Array

The survey also reveals that over 90 percent people wish to be informed in detail about the medicine they are taking and want to have detailed information on them such as for instance their exact use, interactions, potential side effects so on and so forth.

Array

In addition, it also highlights that 72.7 percent people prefer e-bills over normal paper as they wish to keep track of them in a convenient way.

Array

The survey also emphasizes E Pharmacy will significantly improve consumer convenience and access. This will especially help chronic patients with nuclear families, and also patients who are not in a condition to go out to find a pharmacy. Moreover, a normal chemist shop can only keep limited inventory, resulting in a consumer having to ask multiple stores to get his or her medicine.

Array

In a representation submitted to the Drugs Controller General of India, the Chamber has highlighted that in e-pharmacy, order should be processed from a licensed premises only and be dispensed by a registered pharmacist in a licensed premise, adding that scheduled drugs be also sold off only against a valid prescription of a registered medical practitioner as per the Drug and Cosmetic Act.

Array

The Chamber has also pointed out that e- pharmacy should share the details of the licensed pharmacy fulfilling the order with the users using email and SMS.

Array

The Chamber and the 1MG.com are also of the view that Schedule X and other habit forming drugs should not be allowed to be sold through an e-pharmacy model. There should be adequate checks and balances in place to prevent sale of any such drugs.

Array

The PHD Chamber has also emphasized that restrictions ought to be placed on illegal international trade through e-pharmacy since drugs are being shipped across the international borders without any prescription and approval from the concerned authorities.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 30 2015 | 4:52 PM IST

Next Story